Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557036 · ClinicalTrials.gov registry record
Aneurysm Study of Pipeline in an Observational Registry
A clinical trial, sponsored by Medtronic Neurovascular Clinical Affairs.
- Terminated
- Registry status
- 200
- Enrollment target
NCT01557036 is a clinical trial that was terminated before completion, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 200 participants.
The verdict
NCT01557036 was terminated before completion, sponsored by Medtronic Neurovascular Clinical Affairs.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The primary objective of this study is to further expand the body of clinical knowledge in patients undergoing Pipeline Embolization Device (Pipeline or PED) placement for intracranial aneurysms (IAs or ICAs) according to Pipeline's labeled indication.
Interventions
- DEVICE Pipeline Embolization Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-06-21 |
| Est. Completion | 2014-06-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01557036
The ClinicalTrials.gov registry entry for NCT01557036 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pipeline Embolization Device is the first listed.
NCT01557036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01557036 about?
NCT01557036 is a clinical study titled "Aneurysm Study of Pipeline in an Observational Registry". The primary objective of this study is to further expand the body of clinical knowledge in patients undergoing Pipeline Embolization Device (Pipeline or PED) placement for intracranial aneurysms (IAs or ICAs) according to Pipeline's labeled indication.
What is the current status of trial NCT01557036?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2012-06-21. Estimated completion is 2014-06-05.
What interventions are being tested in trial NCT01557036?
The interventions under investigation include: Pipeline Embolization Device (DEVICE).
Who is sponsoring clinical trial NCT01557036?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.